|
Peterson, Erich A; Bauer, Michael A; Chavan, Shweta S et al. (2015) Enhancing cancer clonality analysis with integrative genomics. BMC Bioinformatics 16 Suppl 13:S7
|
|
Khan, R; Apewokin, S; Grazziutti, M et al. (2015) Renal insufficiency retains adverse prognostic implications despite renal function improvement following Total Therapy for newly diagnosed multiple myeloma. Leukemia 29:1195-201
|
|
Barlogie, Bart; Mitchell, Alan; van Rhee, Frits et al. (2014) Curing myeloma at last: defining criteria and providing the evidence. Blood 124:3043-51
|
|
Papanikolaou, Xenofon; Johnson, Sarah; Garg, Tarun et al. (2014) Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis. Oncotarget 5:4118-28
|
|
van Rhee, Frits; Giralt, Sergio; Barlogie, Bart (2014) The future of autologous stem cell transplantation in myeloma. Blood 124:328-33
|
|
Bauer, Michael A; Chavan, Shweta S; Peterson, Erich A et al. (2014) Leveraging the new with the old: providing a framework for the integration of historic microarray studies with next generation sequencing. BMC Bioinformatics 15 Suppl 11:S3
|
|
Peterson, Erich A; Chavan, Shweta S; Bauer, Michael A et al. (2014) Revealing the inherent heterogeneity of human malignancies by variant consensus strategies coupled with cancer clonal analysis. BMC Bioinformatics 15 Suppl 11:S9
|
|
Usmani, Saad Z; Mitchell, Alan; Waheed, Sarah et al. (2013) Prognostic implications of serial 18-fluoro-deoxyglucose emission tomography in multiple myeloma treated with total therapy 3. Blood 121:1819-23
|
|
Chavan, Shweta S; Bauer, Michael A; Peterson, Erich A et al. (2013) Towards the integration, annotation and association of historical microarray experiments with RNA-seq. BMC Bioinformatics 14 Suppl 14:S4
|
|
Usmani, S Z; Crowley, J; Hoering, A et al. (2013) Improvement in long-term outcomes with successive Total Therapy trials for multiple myeloma: are patients now being cured? Leukemia 27:226-32
|
Showing the most recent 10 out of 28 publications
